Oakwood Medical Investors
Search |
Home
About Us
Management Team
Physician Venture Partners
Advisory Committee
Funds
Oakwood Investors I
Oakwood Medical Investors II
Oakwood Medical Investors III
Oakwood Medical Investors IV
News
Oakwood Newsletter
Contact Us
Contact Information
Submit Business Plan
News Detail
Argos Therapeutics Presents Data on the Mechanism of Immunosuppression by Soluble CD83 at the Canadian Society of Transplantation Congress
28 Feb 2008
by:
read the article
|
Contact Us
Site Map
Privacy Policy
Site Credits
Copyright © 2007 Oakwood Medical Investors